| 225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer C Kratochwil, F Bruchertseifer, FL Giesel, M Weis, FA Verburg, F Mottaghy, ... Journal of Nuclear Medicine 57 (12), 1941-1944, 2016 | 1040 | 2016 |
| Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association … RM Tuttle, S Ahuja, AM Avram, VJ Bernet, P Bourguet, GH Daniels, ... Thyroid 29 (4), 461-470, 2019 | 388 | 2019 |
| The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy SA Rivkees, EL Mazzaferri, FA Verburg, C Reiners, M Luster, CK Breuer, ... Endocrine reviews 32 (6), 798-826, 2011 | 269 | 2011 |
| Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement FA Verburg, M Luster, C Cupini, L Chiovato, L Duntas, R Elisei, ... Thyroid 23 (10), 1211-1225, 2013 | 226 | 2013 |
| Life expectancy is reduced in differentiated thyroid cancer patients≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis … FA Verburg, U Mäder, K Tanase, ED Thies, S Diessl, AK Buck, M Luster, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), 172-180, 2013 | 222 | 2013 |
| Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score FA Verburg, D Pfister, A Heidenreich, A Vogg, NI Drude, S Vöö, ... European journal of nuclear medicine and molecular imaging 43, 397-403, 2016 | 205 | 2016 |
| The EANM practice guidelines for parathyroid imaging P Petranović Ovčariček, L Giovanella, I Carrió Gasset, E Hindié, ... European journal of nuclear medicine and molecular imaging 48, 2801-2822, 2021 | 187 | 2021 |
| European perspective on 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: proceedings of an … M Luster, C Aktolun, I Amendoeira, M Barczyński, KC Bible, LH Duntas, ... Thyroid 29 (1), 7-26, 2019 | 178 | 2019 |
| EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy L Giovanella, AM Avram, I Iakovou, J Kwak, SA Lawson, E Lulaj, M Luster, ... European journal of nuclear medicine and molecular imaging 46, 2514-2525, 2019 | 177 | 2019 |
| Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with 68Ga-PSMA-HBED-CC than with 18F-Fluoroethylcholine … D Pfister, D Porres, A Heidenreich, I Heidegger, R Knuechel, F Steib, ... European journal of nuclear medicine and molecular imaging 43, 1410-1417, 2016 | 167 | 2016 |
| First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT FA Verburg, T Krohn, A Heinzel, FM Mottaghy, FF Behrendt European journal of nuclear medicine and molecular imaging 42, 1622-1623, 2015 | 150 | 2015 |
| Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients FA Verburg, B de Keizer, CJM Lips, PMJ Zelissen, JMH de Klerk European Journal of Endocrinology 152 (1), 33-37, 2005 | 149 | 2005 |
| Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late … SC Clement, LCM Kremer, FA Verburg, JH Simmons, M Goldfarb, ... Cancer treatment reviews 63, 28-39, 2018 | 145 | 2018 |
| [68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice T Krohn, FA Verburg, T Pufe, W Neuhuber, A Vogg, A Heinzel, ... European journal of nuclear medicine and molecular imaging 42, 210-214, 2015 | 143 | 2015 |
| EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor-and PSMA-targeting ligands K Sjögreen Gleisner, N Chouin, PM Gabina, F Cicone, S Gnesin, ... European journal of nuclear medicine and molecular imaging 49 (6), 1778-1809, 2022 | 138 | 2022 |
| Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and … FA Verburg, C Aktolun, A Chiti, S Frangos, L Giovanella, M Hoffmann, ... European journal of nuclear medicine and molecular imaging 43, 1001-1005, 2016 | 138 | 2016 |
| Unstimulated highly sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: a meta-analysis L Giovanella, G Treglia, R Sadeghi, P Trimboli, L Ceriani, FA Verburg The Journal of Clinical Endocrinology & Metabolism 99 (2), 440-447, 2014 | 136 | 2014 |
| No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer FA Verburg, MPM Stokkel, C Düren, RBT Verkooijen, U Mäder, ... European journal of nuclear medicine and molecular imaging 37, 276-283, 2010 | 134 | 2010 |
| Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper. L Giovanella, PM Clark, L Chiovato, L Duntas, R Elisei, ... European journal of endocrinology, 2014 | 129 | 2014 |
| Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma S Diessl, B Holzberger, U Mäder, I Grelle, JWA Smit, AK Buck, C Reiners, ... Clinical endocrinology 76 (4), 586-592, 2012 | 127 | 2012 |
Felix MottaghyDepartment of Nuclear Medicine, University Hospital RWTH Aachen UniversityDirección de correo verificada de ukaachen.de
